Alemtuzumab and treatment of chronic lymphocytic leukemia and its immune-related disorders: one player on two tables.
Giovanni
G
D'Arena
Luca
L
Laurenti
D000074323:Alemtuzumab; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D020275:Guillain-Barre Syndrome / Q000188:drug therapy*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications*; D008297:Male
D061067:Antibodies, Monoclonal, Humanized; D000074323:Alemtuzumab